News – Page 439 – Endpoints News

Pfizer declares 'first-ever' PhIII win for RSV vaccine in infants — and it's steering straight to FDA

3 years ago

A single injection of Unity's anti-aging hypothesis bears fruit in PhII, as pivotal plans shape up

3 years ago

Drew Armstrong is coming to Endpoints(!) And there are some more surprises to come

3 years ago

That secretive ARCH biotech with two antibodies from MorphoSys? It’s now got $120M

3 years ago

#CPHI22: Endpoints sits down with conference exec as the manufacturing world says ‘Guten Tag’ to CPHI

3 years ago

#CPHI22: Contract manufacturers will still be navigating global challenges into next year

3 years ago

#CPHI22: Annual report shows ‘moderate outlook’ and focus on mRNA

3 years ago

#CPHI22: A look back at the biggest manufacturing projects in 2022

3 years ago

#CPHI22: Cell and gene manufacturing expected to see a bump as it moves out of the pandemic

3 years ago

#CPHI22: Supply chain woes are still bearing down on manufacturers

3 years ago

Bristol Myers' blockbuster-to-be Reblozyl scores a PhIII win

3 years ago

Daiichi Sankyo sets new highs for AstraZeneca-partnered cancer drug Enhertu

3 years ago

FDA to kick off CMC readiness pilot program next April

3 years ago

AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others

3 years ago

Under hub-and-spoke biotech, serial founders launch new startup hoping to make gene therapies for the eye

3 years ago

Thermo Fisher wagers on early cancer diagnostics in $2.6B cash deal for multiple myeloma test maker

3 years ago

Intrinsic wanted an IPO. Instead, it's a SPAC for the gut-brain microbiome biotech

3 years ago

After years of effort, Actinium meets primary endpoint in pivotal AML trial

3 years ago

GSK warns 50+ crowd to ‘wake up’ to viral danger of shingles in latest campaign

3 years ago

Nuvalent nets $200M public offering in wake of positive PhI data, paving way for future trials

3 years ago

J&J presses pause on a partner's PhI prostate cancer study, cutting off potential Erleada combo

3 years ago

A Dallas biotech halts TIL therapy trials — shares crater nearly 30%

3 years ago

China bans GSK from drug procurement activities through April 2024

3 years ago

AbbVie discards PhIIb autoimmune drug from 10-year-old discovery pact, citing chronic toxicology study

3 years ago

First page Previous page 436 437 438439440 441 442 Next page Last page